Results 111 to 120 of about 857 (121)

Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors

ESMO Open, 2023
exaly  

A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours

Investigational New Drugs, 2018
Ben Tran, Gaurav Bajaj, Anna Spreafico
exaly  

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

ACS Medicinal Chemistry Letters, 2018
Lawrence R Marcin, Hyunsoo Park, James Kempson   +2 more
exaly  

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation

Arteriosclerosis, Thrombosis, and Vascular Biology, 2018
zhaoqing wang
exaly  

Synthesis and biological evaluation of BMS-986120 and its deuterated derivatives as PAR4 antagonists

Bioorganic and Medicinal Chemistry, 2019
Yi Kong, Hongbin Sun
exaly  

The δ‐opioid receptor positive allosteric modulator BMS 986187 is a G‐protein‐biased allosteric agonist

British Journal of Pharmacology, 2019
M Alexander Stanczyk, Kathryn E Livingston, Louise Chang   +2 more
exaly  

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868

British Journal of Cancer, 1999
Simon P Langdon
exaly  

Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice

Endocrinology, 2018
Jan Kroon, Lisa L Koorneef, Nienke M Van De Velde   +2 more
exaly  

SEP-225289 Serotonin and Dopamine Transporter Occupancy: A PET Study

Journal of Nuclear Medicine, 2011
Christine DeLorenzo, Sarah D Lichenstein
exaly  

Case 25282

New England Journal of Medicine, 1939
exaly